BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15867182)

  • 1. Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study.
    Klein L; O'Connor CM; Leimberger JD; Gattis-Stough W; Piña IL; Felker GM; Adams KF; Califf RM; Gheorghiade M;
    Circulation; 2005 May; 111(19):2454-60. PubMed ID: 15867182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spot urinary sodium as a prognostic marker for mortality in patients with acute decompensated heart failure.
    Londoño JM; Betancur KJ; Fonseca L; Fonseca P; Cañas EM; Saldarriaga CI
    Biomedica; 2023 Dec; 43(Sp. 3):41-50. PubMed ID: 38207157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of serum albumin with heart failure mortality with NYHA class IV in Chinese patients: Insights from PhysioNet database (version 1.3).
    Chen Y; Cai XB; Yao X; Zhang SH; Cai MH; Li HP; Jing XB; Zhang YG; Ding QF
    Heart Lung; 2024; 65():72-77. PubMed ID: 38432040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-Term Mortality in Hospitalized Patients with Congestive Heart Failure: Markers of Thrombo-Inflammation Are Independent Risk Factors and Only Weakly Associated with Renal Insufficiency and Co-Morbidity Burden.
    Iglesias J; Okoh N; Ang SP; Rodriguez CA; Chia JE; Levine JS
    J Cardiovasc Dev Dis; 2024 Mar; 11(3):. PubMed ID: 38535116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry.
    Gheorghiade M; Abraham WT; Albert NM; Gattis Stough W; Greenberg BH; O'Connor CM; She L; Yancy CW; Young J; Fonarow GC;
    Eur Heart J; 2007 Apr; 28(8):980-8. PubMed ID: 17309900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial.
    Gheorghiade M; Rossi JS; Cotts W; Shin DD; Hellkamp AS; Piña IL; Fonarow GC; DeMarco T; Pauly DF; Rogers J; DiSalvo TG; Butler J; Hare JM; Francis GS; Stough WG; O'Connor CM
    Arch Intern Med; 2007 Oct; 167(18):1998-2005. PubMed ID: 17923601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) trial.
    Rossi J; Bayram M; Udelson JE; Lloyd-Jones D; Adams KF; Oconnor CM; Stough WG; Ouyang J; Shin DD; Orlandi C; Gheorghiade M
    Acute Card Care; 2007; 9(2):82-6. PubMed ID: 17573581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyponatremia and in-hospital mortality in patients admitted for heart failure (from the ATTEND registry).
    Sato N; Gheorghiade M; Kajimoto K; Munakata R; Minami Y; Mizuno M; Aokage T; Asai K; Sakata Y; Yumino D; Mizuno K; Takano T;
    Am J Cardiol; 2013 Apr; 111(7):1019-25. PubMed ID: 23312128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and prognostic significance of hyponatraemia in outpatients with chronic heart failure.
    Balling L; Schou M; Videbæk L; Hildebrandt P; Wiggers H; Gustafsson F;
    Eur J Heart Fail; 2011 Sep; 13(9):968-73. PubMed ID: 21743065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).
    Dickstein K; Cohen-Solal A; Filippatos G; McMurray JJ; Ponikowski P; Poole-Wilson PA; Strömberg A; van Veldhuisen DJ; Atar D; Hoes AW; Keren A; Mebazaa A; Nieminen M; Priori SG; Swedberg K;
    Eur Heart J; 2008 Oct; 29(19):2388-442. PubMed ID: 18799522
    [No Abstract]   [Full Text] [Related]  

  • 11. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
    Abraham WT; Adams KF; Fonarow GC; Costanzo MR; Berkowitz RL; LeJemtel TH; Cheng ML; Wynne J; ;
    J Am Coll Cardiol; 2005 Jul; 46(1):57-64. PubMed ID: 15992636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial.
    Konstam MA; Gheorghiade M; Burnett JC; Grinfeld L; Maggioni AP; Swedberg K; Udelson JE; Zannad F; Cook T; Ouyang J; Zimmer C; Orlandi C;
    JAMA; 2007 Mar; 297(12):1319-31. PubMed ID: 17384437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyponatremia as predictor of worse outcome in real world patients admitted with acute heart failure.
    Arévalo Lorido JC; Carretero Gómez J; Formiga F; Montero Pérez-Barquero M; Trullás Vila JC; Aramburu Bodas O; Ceresuela LM;
    Cardiol J; 2013; 20(5):506-12. PubMed ID: 24469874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of hyponatremia among ambulatory patients with heart failure and preserved and reduced ejection fractions.
    Bavishi C; Ather S; Bambhroliya A; Jneid H; Virani SS; Bozkurt B; Deswal A
    Am J Cardiol; 2014 Jun; 113(11):1834-8. PubMed ID: 24837261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyponatremia is an independent predictor of adverse clinical outcomes in hospitalized patients due to worsening heart failure.
    Hamaguchi S; Kinugawa S; Tsuchihashi-Makaya M; Matsushima S; Sakakibara M; Ishimori N; Goto D; Tsutsui H
    J Cardiol; 2014 Mar; 63(3):182-8. PubMed ID: 24021776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF).
    Klein L; Massie BM; Leimberger JD; O'Connor CM; Piña IL; Adams KF; Califf RM; Gheorghiade M;
    Circ Heart Fail; 2008 May; 1(1):25-33. PubMed ID: 19808267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between Baseline Hyponatremia and Activities of Daily Living and Muscle Health in Convalescent Stroke Patients.
    Yoshimura Y; Wakabayashi H; Nagano F; Matsumoto A; Shimazu S; Shiraishi A; Kido Y; Bise T; Kuzuhara A; Hori K; Hamada T; Yoneda K; Maekawa K
    Prog Rehabil Med; 2024; 9():20240019. PubMed ID: 38827580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of hyponatremia for short-term mortality in supratentorial spontaneous intracerebral hemorrhage: a single center study.
    Qian A; Zheng L; He Z; Zhou J; Tang S; Xing W
    Front Neurol; 2024; 15():1301197. PubMed ID: 38333609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality predictors of patients diagnosed with severe hyponatremia in the emergency department.
    Gurbuz M; Acehan S; Satar S; Gulen M; Sevdımbas S; Ince C; Onan E
    Ir J Med Sci; 2024 Jun; 193(3):1561-1572. PubMed ID: 38291136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congestion in Heart Failure: From the Secret of a Mummy to Today's Novel Diagnostic and Therapeutic Approaches: A Comprehensive Review.
    Alevroudis I; Kotoulas SC; Tzikas S; Vassilikos V
    J Clin Med; 2023 Dec; 13(1):. PubMed ID: 38202020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.